Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial
Open Access
- 18 February 2025
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (8) , 1276-1289
Abstract
Background: Advice to avoid dietary emulsifiers in Crohn's disease (CD) is based on preclinical data.Aims: To examine the effect of diets high (HED) and low (LED) in emulsifiers in the food supply on disease activity in CD.Methods: In a double‐blinded, randomised feeding study, we randomised adults with symptomatic, sonographically active CD with ileal involvement on ≥ 2 months' stable medical therapy to 4 weeks of a HED or LED modelled on Australian healthy eating guidelines. We measured the Harvey‐Bradshaw Index (HBI), sonographic indices (IBUS‐SAS, bowel wall thickness), quality of life (QOL) and fatigue at baseline and study completion.Results: We randomised 24 patients, mean age 37 (95% CI 32, 41) years, 12 male, HBI 6 (6, 8), bowel wall thickness 6.0 (5.5–6.6) mm. Adherence was > 95%. Clinical remission (HBI < 5) occurred in 9/12 on HED and 7/12 on LED; 2 and 3, respectively, withdrew early with increasing gastrointestinal symptoms. IBUS‐SAS fell from 51 (35, 68) to 33 (15, 51) on HED (p = 0.014) and from 57 (38, 76) to 44 (29, 59) on LED (p = 0.01). Bowel wall thickness reduced by 34% on HED and 15% on LED in those who completed the study. QOL and fatigue improved on both diets (p ≤ 0.05). There were no statistically significant differences in outcomes between diets.Conclusions: In the context of a healthy diet, the emulsifier content had no influence over disease activity over 4 weeks in patients with CD. Recommendations to avoid emulsifiers in patients with active CD are not supported.Australian New Zealand Clinical Trials Registry (ACTRN12619001099112).Keywords
Funding Information
- National Health and Medical Research Council
- Crohn's and Colitis Foundation
- Crohn's and Colitis Australia
This publication has 50 references indexed in Scilit:
- ESPEN guideline on Clinical Nutrition in inflammatory bowel diseaseClinical Nutrition, 2023
- Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2022
- Evaluating tolerability of resistant starch 2, alone and in combination with minimally fermented fibre for patients with irritable bowel syndrome: a pilot randomised controlled cross-over trialJournal of Nutritional Science, 2022
- The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trialThe Lancet Gastroenterology & Hepatology, 2022
- Impact of food additives on the composition and function of gut microbiota: A reviewTrends in Food Science & Technology, 2020
- Dietary Guidance From the International Organization for the Study of Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology, 2020
- The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processingPublic Health Nutrition, 2017
- Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's diseaseJournal of Crohn's and Colitis, 2013
- A new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology, 1989
- Development of a Crohn's Disease Activity IndexGastroenterology, 1976